Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined Vaccine

Conditions

• Diphtheria, Tetanus and Acellular Pertussis
• Epidemic Meningitis
• Haemophilus Influenzae Type B Infection

Interventions

• BIOLOGICAL: Adsorbed Acellular Pertussis (3-Component) Diphtheria-Tetanus-Pertussis-Haemophilus influenzae type b (Conjugate)-Meningococcal Group ACYW135 (Conjugate) Combined Vaccine (DTcP-Hib-MCV4)
• BIOLOGICAL: DTcP-Hib-MCV4
• BIOLOGICAL: DTcP-Hib-MCV4
• BIOLOGICAL: DTcP-Hib-MCV4
• BIOLOGICAL: DTcP-Hib-MCV4
• BIOLOGICAL: Adsorbed Acellular Pertussis (3-Component) Diphtheria-Tetanus-Pertussis (DTcP)
• BIOLOGICAL: Haemophilus influenzae type b (Conjugate) (Hib)
• BIOLOGICAL: Meningococcal Group ACYW135 (Conjugate) (MCV4)
• BIOLOGICAL: MCV4
• BIOLOGICAL: MCV4
• OTHER: Sodium Chloride Injection (0.9%) (Saline Solution) (NS)

Sponsor

CanSino Biologics Inc.